Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bedgebury Communications is a specialist healthcare communications agency that provides strategic medical education and publication planning services to the pharmaceutical and biotechnology industries. The company focuses on delivering evidence-based scientific content and communication strategies to support product launches and lifecycle management. In 2012, Bedgebury was acquired by Envision Pharma Group, a global leader in technology-enabled scientific communications. This acquisition allowed Envision to enhance its strategic medical affairs and consultancy capabilities. Today, the legacy of Bedgebury's expertise continues within the integrated service offerings of the Envision Pharma Group, serving a diverse range of therapeutic areas.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bedgebury Communications.